Latest Breaking News On - Acute exacerbations - Page 1 : comparemela.com

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial | Chronic Obstructive Pulmonary Disease | JAMA

This study examines whether the addition of bisoprolol to treatment of people with chronic obstructive pulmonary disease (COPD) at high risk of

United statesCity ofUnited kingdomSan diegoParticipantsthe bisoprololSanofi genzymeGraham devereuxAmerican thoracic society european respiratoryManchester biomedical research centreHealth services research unitScotlanda research ethics committeePragmatic research institute singaporeCare researchLothian respiratory managed clinical networkHull airway reflux questionnaireCentre for healthcare randomized trials

β-Blockers in Chronic Obstructive Pulmonary Disease—Walking the Tightrope | Chronic Obstructive Pulmonary Disease | JAMA

Cardiovascular disease in chronic obstructive pulmonary disease (COPD) is common and the leading cause of death among patients with mild to moderate

United statesMeilank hanDepartment of defenseApreo healthBoehringer ingelheimE medical center drAmerican lung associationAcute exacerbationsChronic obstructive pulmonary diseaseAnn arborInterest disclosuresGala therapeuticsAer therapeutics

Allergic Rhinitis - Symptoms - Diagnosis - Treatment - Prevention

Allergic rhinitis (AR) causes a collection of symptoms, mostly in the nose and eyes and occurs when one breathes in allergens that leads to its inflammation.

United statesNithin jayanPerennial allergic rhinitisMerck manualAllergic rhinitisSymptoms improvementIntranasal triamcinoloneIntranasal fluticasone propionateFactors associatedAcute exacerbations

Pulmatrix Announces Third Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious disease.

Timothy mccarthyTed raadPulmatrix incHc wainwright coCompany quarterly reports on formChief executive officerAllergic bronchopulmonary aspergillosisRecent programAcute exacerbationsChronic obstructive pulmonary diseaseCipla agreementAt the market sales agreementPrivate securities litigation reform actAnnual reportQuarterly reports

Pulmatrix Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Pulmatrix Announces Third Quarter 2022 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Timothy mccarthyTed raadPulmatrix incHc wainwright coCompany quarterly reports on formChief executive officerAllergic bronchopulmonary aspergillosisRecent programAcute exacerbationsChronic obstructive pulmonary diseaseCipla agreementAt the market sales agreementInc pulmatrixLooking statementscertainPrivate securities litigation reform actAnnual report